Immunoassay of infectious agents

BioTechniques

Volumn 35, Issue 4, 2003, Pages 850-859

  Andreotti, Peter E ^a   Ludwig, George V ^b   Peruski, Anne Harwood ^c   Tuite, James J ^a   Morse, Stephen S ^d   Peruski Jr , Leonard F ^c  

^a ASD Biosystems Inc   (United States)

^b US Army Medical Research   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE NORTHWEST   (United States)

^d Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BIOASSAY; IMMUNOLOGY;

IMMUNOASSAYS;

BIOTECHNOLOGY;

HUMAN INSULIN;

ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; BIOLOGICAL WARFARE; IMMUNE RESPONSE; IMMUNOASSAY; INFECTION; NONHUMAN; NUCLEIC ACID ANALYSIS; RADIOIMMUNOASSAY; REVIEW; SERODIAGNOSIS;

EID: 0141960811     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/03354ss02     Document Type: Review

References (85)

1. O'Sullivan, C.K. 2002. Aptasensors - the future of biosensing? Anal. Bioanal. Chem. 372:44-48.
2. Iqbal, S.S., M.W. Mayo, J.G. Bruno, B.V. Bronk, C.A. Batt, and J.P. Chambers. 2000. A review of molecular recognition technologies for detection of biological threat agents. Biosens. Bioelectron. 15:549-578.
3. Jayasena, S.D. 1999. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin. Chem. 45:1628-1650.
4. Lu, Z., K.S. Murray, V. Van Cleave, E.R. LaVallie, M.L. Stahl, and J.M. McCoy. 1995. Expression of thioredoxin random peptide libraries on the Escherichia coli cell surface as functional fusions to flagellin: a system designed for exploring protein-protein interactions. Biotechnology (NY) 13:366-372.
5. Kurz, M., K. Gu, A. Al-Gawari, and P.A. Lohse. 2001. cDNA-protein fusions: covalent protein-gene conjugates for the in vitro selection of peptides and proteins. Chembiochem. 2:666-672.
6. Harlow, E. and D. Lane. 1988. Antibodies: A Laboratory Manual. CSH Laboratory Press, Cold Spring Harbor, NY.
7. Kohler, G. and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497.
8. De Jong, J.C., G.F. Rimmelzwaan, R.A. Fouchier, and A.D. Osterhaus. 2000. Influenza virus: a master of metamorphosis. J. Infect. 40:218-228.
9. Agapov, E.V., S.D. Lebedeva, I.A. Razumov, I.V. Frolov, A.A. Kolykhalov, V.B. Loktev, S.V. Netesov, and L.S. Sandakhchiev. 1991. [Variants of the Venezuelan equine encephalomyelitis virus resistant to the neutralizing action of monoclonal antibodies]. Dokl. Akad. Nauk. SSSR 320: 1485-1488.
10. Allison, L.M., M.W. Salter, S. Kiguwa, and C.R. Howard. 1991. Analysis of the glycoprotein gene of Tacaribe virus and neutralization-resistant variants. J. Gen. Virol. 72:2025-2029.
11. Ketterlinus, R., K. Wiegers, and R. Dernick. 1993. Revertants of poliovirus escape mutants: new insights into antigenic structures. Virology 192:525-533.
12. Burton, D.R., C.F. Barbas III, M.A. Persson, S. Koenig, R.M. Chanock, and R.A. Lerner. 1991. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc. Natl. Acad. Sci. USA 88:10134-10137.
13. Nakayama, G.R., G. Valkirs, D. McGrath, and W.D. Huse. 1996. Improving the copy numbers of antibody fragments expressed on the major coat protein of bacteriophage M13. Immunotechnology 2:197-207.
14. Krebs, B., R. Rauchenberger, S. Reiffert, C. Rothe, M. Tesar, E. Thomassen, M. Cao, T. Dreier, et al. 2001. High-throughput generation and engineering of recombinant human antibodies. J. Immunol. Methods 254:67-84.
15. Crowe, J.E., Jr., B.R. Murphy, R.M. Chanock, R.A. Williamson, C.F. Barbas III, and D.R. Burton. 1994. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc. Natl. Acad. Sci. USA 91:1386-1390.
16. Kreider, B.L. 2000. PROfusion: genetically tagged proteins for functional proteomics and beyond. Med. Res. Rev. 20:212-215.
17. Tuerk, C. and L. Gold. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505-510.
18. Brody, E.N. and L. Gold. 2000. Aptamers as therapeutic and diagnostic agents. J. Biotechnol. 74:5-13.
19. Eaton, B.E. and W.A. Pieken. 1995. Ribonucleosides and RNA. Annu. Rev. Biochem. 64:837-863.
20. Ruckman, J., L.S. Green, J. Beeson, S. Waugh, W.L. Gillette, D.D. Henninger, L. Claesson-Welsh, and N. Janjic. 1998. 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J. Biol. Chem. 273:20556-20567.
21. Jellinek, D., L.S. Green, C. Bell, C.K. Lynott, N. Gill, C. Vargeese, G. Kirschenheuter, D.P. McGee, et al. 1995. Potent 2′-amino-2′ -deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry 34:11363-11372.
22. Peruski, A.H., L.H. Johnson III, and L.F. Peruski, Jr. 2002. Rapid and sensitive detection of biological warfare agents using time-resolved fluorescence assays. J. Immunol. Methods 263:35-41.
23. Schotte, U., N. Langfeldt, A.H. Peruski, and H. Meyer. 2002. Detection of staphylococcal enterotoxin B (SEB) by enzyme-linked immunosorbent assay and by a rapid hand-held assay. Clin. Lab. 48:395-400.
24. Smith, D.R., C.A. Rossi, T.M. Kijek, E.A. Henchal, and G.V. Ludwig. 2001. Comparison of dissociation-enhanced lanthanide fluorescent immunoassays to enzyme-linked immunosorbent assays for detection of staphylococcal enterotoxin B, Yersinia pestis-specific F1 antigen, and Venezuelan equine encephalitis virus. Clin. Diagn. Lab. Immunol. 8: 1070-1075.
25. Voller, A., D. Bidwell, and A. Bartlett. 1980. Enzyme-linked immunosorbent assay, p. 359-371. In N.R. Rose and H. Friedman (Eds.), Manual of Clinical Immunology. American Society of Microbiology, Washington, DC.
26. Andreotti, P.E., R. Meyer, T. Campbell, M.T. Goode, D.L. Menking, E.D. Myers, T. Palenius, and L. Stanker. 2001. Detection and identification of animal and food pathogens using time-resolved fluorescence, p. 4857. In Y.-R. Chen and S.-I. Tu (Eds.), Photonic Detection and Intervention Technologies for Safe Food. Proceedings of SPIE.
27. Kricka, L.J. 1991. Chemiluminescent and bioluminescent techniques. Clin. Chem. 37:1472-1481.
28. Engvall, E. and P. Perlmann. 1972. Enzyme-linked immunosorbent assay, ELISA. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J. Immunol. 109:129-135.
29. Tu, S.-I., M.C. Golden, and P.E. Andreotti. 2001. Simultaneous detection of E. coli O157:H7 and Salmonella typhimurium in foods using time-resolved fluorescence of lanthanides. In Proceedings of United States-Japan Natural Resources Panel. Tsukuba, Japan.
30. Berson, S.A. and R.S. Yalow. 1959. Quantitative aspects of the reaction between insulin and insulin binding antibody. J. Clin. Invest. 38:1996-2016.
31. Engvall, E. and P. Perlmann. 1971. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 8:871-874.
32. Higgins, J.A., M.S. Ibrahim, F.K. Knauert, G.V. Ludwig, T.M. Kijek, J.W. Ezzell, B.C. Courtney, and E.A. Henchal. 1999. Sensitive and rapid identification of biological threat agents. Ann. NY Acad. Sci. 894: 130-148.
33. Henchal, E.A., J.D. Teska, G.V. Ludwig, D.R. Shoemaker, and J.W. Ezzell. 2001. Current laboratory methods for biological threat agent identification. Clin. Lab. Med. 21:661-678.
34. Peruski, A.H. and L.F. Peruski, Jr. 2003. Immunological methods for detection and identification of infectious disease and biological warfare agents. Clin. Diagn. Lab. Immunol. 10:506-513.
35. Ludwig, G.V., C.A. Rossi, and R.L. Bull. 2003. Concepts for the development of immunodiagnostic assays for detection and diagnosis of biothreat agents, in press. In L. Lindler, G. Korch and F. Lobeda (Eds.), Biological Weapons Defense: Principles and Mechanisms for Infectious Diseases Counter-Bioterrorism. Humana Press, Totowa.
36. Kricka, L.J. 1996. The clinical and research potential of bioluminescence and chemiluminescence in medicine, p. 171-178. In L.J. Kricka, P.E. Stanley, and A.K. Campbell (Eds.), Bioluminescence and Chemiluminescence: Fundamentals and Applied Aspects. John Wiley & Sons, Chichester.
37. Weeks, I. and J.S. Woodhead. 1991. Chemiluminescent assays based on acridinium labels, p. 553-556. In P.E. Stanley and L.J. Kricka (Eds.), Bioluminescence and Chemiluminescence: Current Status. John Wiley & Sons, Chichester.
38. Yang, H., J.K. Leland, D. Yost, and R.J. Massey. 1994. Electrochemiluminescence: a new diagnostic and research tool. ECL detection technology promises scientists new "yardsticks" for quantification. Biotechnology (NY) 12:193-194.
39. Kijek, T.M., C.A. Rossi, D. Moss, R.W. Parker, and E.A. Henchal. 2000. Rapid and sensitive immunomagnetic-electrochemiluminescent detection of staphyloccocal enterotoxin B. J. Immunol. Methods 236:9-17.
40. Barnard, G., B. Helmick, S. Madden, C. Gilbourne, and R. Patel. 2000. The measurement of prion protein in bovine brain tissue using differential extraction and DELFIA as a diagnostic test for BSE. Luminescence 15:357-362.
41. Crooks, S.R., P. Ross, C.S. Thompson, S.A. Haggan, and C.T. Elliott. 2000. Detection of unwanted residues of ivermectin in bovine milk by dissociation-enhanced lanthanide fluoroimmunoassay. Luminescence 15: 371-376.
42. Hierholzer, J.C., K.H. Johansson, L.J. Anderson, C.J. Tsou, and P.E. Halonen. 1987. Comparison of monoclonal time-resolved fluoroimmunoassay with monoclonal capture-biotinylated detector enzyme immunoassay for adenovirus antigen detection. J. Clin. Microbiol. 25:1662-1667.
43. Hemmila, I., S. Dakubu, V.M. Mukkala, H. Siitari, and T. Lovgren. 1984. Europium as a label in time-resolved immunofluorometric assays. Anal. Biochem. 137:335-343.
44. Zuk, R.F., V.K. Ginsberg, T. Gouts, J. Rabbie, H. Merrick, E.F. Ullman, M.M. Fischer, C.C. Sizto, et al. 1985. Enzyme immunochromatography-a quantitative immunoassay requiring no instrumentation. Clin. Chem. 31:1144-1150.
45. Corstjens, P., M. Zuiderwijk, A. Brink, S. Li, H. Feindt, R.S. Niedbala, and H. Tanke. 2001. Use of up-converting phosphor reporters in lateral-flow assays to detect specific nucleic acid sequences: a rapid, sensitive DNA test to identify human papillomavirus type 16 infection. Clin. Chem. 47:1885-1893.
46. Niedbala, R.S., H. Feindt, K. Kardos, T. Vail, J. Burton, B. Bielska, S. Li, D. Milunic, et al. 2001. Detection of analytes by immunoassay using up-converting phosphor technology. Anal. Biochem. 293:22-30.
47. Carson, R.T. and D.A. Vignali. 1999. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J. Immunol. Methods 227:41-52.
48. Perrin, F. 1926. Radium. J. Phys. 7:390-401.
49. Checovich, W.J., R.E. Bolger, and T. Burke. 1995. Fluorescence polarization-a new tool for cell and molecular biology. Nature 375:254-256.
50. Tencza, S.B., K.R. Islam, V. Kalia, M.S. Nasir, M.E. Jolley, and R.C. Montelaro. 2000. Development of a fluorescence polarization-based diagnostic assay for equine infectious anemia virus. J. Clin. Microbiol. 38:1854-1859.
51. LeTilly, V. and C.A. Royer. 1993. Fluorescence anisotropy assays implicate protein-protein interactions in regulating trp repressor DNA binding. Biochemistry 32:7753-7758.
52. Nielsen, K., D. Gall, M. Jolley, G. Leishman, S. Balsevicius, P. Smith, P. Nicoletti, and F. Thomas. 1996. A homogeneous fluorescence polarization assay for detection of antibody to Brucella abortus. J. Immunol. Methods 195:161-168.
53. Maeda, H. 1979. Assay of proteolytic enzymes by the fluorescence polarization technique. Anal. Biochem. 92:222-227.
54. Bolger, R., F. Lenoch, E. Allen, B. Meiklejohn, and T. Burke. 1997. Fluorescent dye assay for detection of DNA in recombinant protein products. BioTechniques 23:532-537.
55. Singh, K.K., T. Rucker, A. Hanne, R. Parwaresch, and G. Krupp. 2000. Fluorescence polarization for monitoring ribozyme reactions in real time. BioTechniques 29:344-351.
56. Urios, P. and N. Cittanova. 1990. Adaptation of fluorescence polarization immunoassay to the assay of macromolecules. Anal. Biochem. 185: 308-312.
57. Downs, W.G. 1982. The Rockefeller Foundation virus program: 1951-1971 with update to 1981. Annu. Rev. Med. 33:1-29.
58. Morse, S.S. 1995. Factors in the emergence of infectious diseases. Emerg. Infect. Dis. 1:7-15.
59. Centers for Disease Control. 1993. Update: hantavirus disease-United States, 1993. MMWR Morb. Mortal. Wkly. Rep. 42:612-614.
60. Centers for Disease Control. 1993. Progress in the development of hantavirus diagnostic assays-United States. MMWR Morb. Mortal. Wkly. Rep. 42:770-771.
61. Ksiazek, T.G., C.J. Peters, P.E. Rollin, S. Zaki, S. Nichol, C. Spiropoulou, S. Morzunov, H. Feldmann, et al. 1995. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am. J. Trop. Med. Hyg. 52:117-123.
62. Nichol, S.T., C.F. Spiropoulou, S. Morzunov, P.E. Rollin, T.G. Ksiazek, H. Feldmann, A. Sanchez, J. Childs, et al. 1993. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262:914-917.
63. Gao, S.J. and P.S. Moore. 1996. Molecular approaches to the identification of unculturable infectious agents. Emerg. Infect. Dis. 2:159-167.
64. Moore, P.S. 2000. The emergence of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). N. Engl. J. Med. 343:1411-1413.
65. Relman, D.A. 1999. The search for unrecognized pathogens. Science 284:1308-1310.
66. Giesecke, J. 2002. Modern Infectious Disease Epidemiology. Arnold, London.
67. Nash, D., F. Mostashari, A. Fine, J. Miller, D. O'Leary, K. Murray, A. Huang, A. Rosenberg, et al. 2001. The outbreak of West Nile virus infection in the New York City area in 1999. N. Engl. J. Med. 344:1807-1814.
68. Mostashari, F., M.L. Bunning, P.T. Kitsutani, D.A. Singer, D. Nash, M.J. Cooper, N. Katz, K.A. Liljebjelke, et al. 2001. Epidemic West Nile encephalitis, New York. 1999: results of a household-based seroepidemiological survey. Lancet 358:261-264.
69. Galel, S.A., J.D. Lifson, and E.G. Engleman. 1995. Prevention of AIDS transmission through screening of the blood supply. Annu. Rev. Immunol. 13:201-227.
70. Busch, M., M. Chamberland, J. Epstein, S. Kleinman, R. Khabbaz, and G. Nemo. 1999. Oversight and monitoring of blood safety in the United States. Vox Sang. 77:67-76.
71. Anonymous. 1996. U.S. Public Health Service guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen. MMWR Recomm. Rep. 45:1-9.
72. Nielsen, K. and Y.J. Bryson. 2000. Diagnosis of HIV infection in children. Pediatr. Clin. North. Am. 47:39-63.
73. Nakamura, R.M., D.J. Bylund, and K.E. Rooney. 1990. Current status of clinical laboratory tests for the human immunodeficiency virus. J. Clin. Lab. Anal. 4:295-306.
74. Koch, W.H., P.S. Sullivan, C. Roberts, K. Francis, R. Downing, T.D. Mastro, J. Nkengasong, D. Hu, et al. 2001. Evaluation of United States-licensed human immunodeficiency virus immunoassays for detection of group M viral variants. J. Clin. Microbiol. 39:1017-1020.
75. Cordes, R.J. and M.E. Ryan. 1995. Pitfalls in HIV testing. Application and limitations of current tests. Postgrad. Med. 98:177-189.
76. Jackson, J.B., J.S. Parsons, L.S. Nichols, N. Knoble, S. Kennedy, and E.M. Piwowar. 1997. Detection of human immunodeficiency virus type 1 (HIV-1) antibody by western blotting and HIV-1 DNA by PCR in patients with AIDS. J. Clin. Microbiol. 35:1181-1121.
77. Nuwayhid, N.F. 1995. Laboratory tests for detection of human immunodeficiency virus type 1 infection. Clin. Diagn. Lab. Immunol. 2:637-645.
78. Salgado, C.D., H.L. Flanagan, D.M. Haverstick, and B.M. Farr. 2002. Low rate of false-positive results with use of a rapid HIV test. Infect. Control. Hosp. Epidemiol. 23:335-337.
79. Ketema, F., C. Zeh, D.C. Edelman, R. Saville, and N.T. Constantine. 2001. Assessment of the performance of a rapid, lateral flow assay for the detection of antibodies to HIV. J. Acquir. Immune Defic. Syndr. 27: 63-70.
80. Respess, R.A., M.A. Rayfield, and T.J. Dondero. 2001. Laboratory testing and rapid HIV assays: applications for HIV surveillance in hard-to-reach populations. AIDS 15(Suppl. 3):S49-S59.
81. Hashida, S., K. Hashinaka, S. Ishikawa, and E. Ishikawa. 1997. More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review. J. Clin. Lab. Anal. 11:267-286.
82. Schupbach, J. 2002. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA. AIDS Rev. 4:83-92.
83. Dill, K., L.H. Stanker, and C.R. Young. 1999. Detection of salmonella in poultry using a silicon chip-based biosensor. J. Biochem. Biophys. Methods 41:61-67.
84. Wu, G., R.H. Datar, K.M. Hansen, T. Thundat, R.J. Cote, and A. Majumdar. 2001. Bioassay of prostate-specific antigen (PSA) using microcantilevers. Nat. Biotechnol. 19:856-860.
85. Rider, T.H., M.S. Petrovick, F.E. Nargi, J.D. Harper, E.D. Schwoebel, R.H. Mathews, D.J. Blanchard, L.T. Bortolin, et al. 2003. A B cell-based sensor for rapid identification of pathogens. Science 301:213-215.